UnitedHealth Group Inc (NYSE:UNH) announced a quarterly dividend on Wednesday, February 14th, RTT News reports. Shareholders of record on Friday, March 9th will be paid a dividend of 0.75 per share by the healthcare conglomerate on Tuesday, March 20th. This represents a $3.00 annualized dividend and a yield of 1.32%.

UnitedHealth Group has increased its dividend by an average of 27.0% per year over the last three years and has increased its dividend annually for the last 8 consecutive years. UnitedHealth Group has a dividend payout ratio of 30.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect UnitedHealth Group to earn $14.01 per share next year, which means the company should continue to be able to cover its $3.00 annual dividend with an expected future payout ratio of 21.4%.

Shares of UnitedHealth Group (NYSE UNH) traded up $0.47 during mid-day trading on Wednesday, reaching $227.11. 434,812 shares of the company’s stock traded hands, compared to its average volume of 4,175,031. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. The firm has a market capitalization of $219,630.00, a P/E ratio of 23.94, a PEG ratio of 1.32 and a beta of 0.70. UnitedHealth Group has a 1 year low of $156.49 and a 1 year high of $250.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the business posted $2.11 earnings per share. research analysts forecast that UnitedHealth Group will post 12.51 earnings per share for the current fiscal year.

Several brokerages have issued reports on UNH. Leerink Swann restated a “buy” rating and set a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Cantor Fitzgerald raised their price objective on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research report on Wednesday, October 18th. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Finally, Citigroup lifted their price target on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $243.22.

In related news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the sale, the director now owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares in the company, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold 53,396 shares of company stock worth $12,262,067 in the last quarter. Company insiders own 0.89% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Highland Private Wealth Management grew its position in UnitedHealth Group by 0.4% in the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock worth $593,000 after purchasing an additional 13 shares in the last quarter. Intellectus Partners LLC grew its position in UnitedHealth Group by 18.2% in the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock worth $152,000 after purchasing an additional 126 shares in the last quarter. M&R Capital Management Inc. grew its position in UnitedHealth Group by 14.8% in the 2nd quarter. M&R Capital Management Inc. now owns 1,550 shares of the healthcare conglomerate’s stock worth $299,000 after purchasing an additional 200 shares in the last quarter. Coldstream Capital Management Inc. grew its position in shares of UnitedHealth Group by 37.8% during the 2nd quarter. Coldstream Capital Management Inc. now owns 1,698 shares of the healthcare conglomerate’s stock valued at $315,000 after acquiring an additional 466 shares during the period. Finally, Asymmetry Capital Management L.P. grew its position in shares of UnitedHealth Group by 2.1% during the 2nd quarter. Asymmetry Capital Management L.P. now owns 25,918 shares of the healthcare conglomerate’s stock valued at $4,806,000 after acquiring an additional 526 shares during the period. 86.00% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Inc (UNH) Plans $0.75 Quarterly Dividend” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/02/14/unitedhealth-group-inc-unh-plans-0-75-quarterly-dividend.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Dividend History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.